BCLI
BRAINSTORM CELL THERAPEUTICS INC.
NASDAQ · Healthcare · Biotechnology · US
$0.77
−1.17%Leverage
- Debt / equity
- -0.12x
- Net debt / equity
- -0.12x
- Debt / assets
- 2.91x
- Debt / EBITDA
- -0.14x
- Net debt / EBITDA
- -0.14x
Liquidity & coverage
- Current ratio
- 0.03x
- Quick ratio
- 0.03x
- Cash ratio
- 0.00x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$12.1M
Cash & dividend
- FCF / debt
- -2.95x
- Cash flow / debt
- -2.95x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026